Tuesday, December 01, 2015 10:51:36 AM
Interestingly, this report indicates that Medline's Silvertouch Foley catheter had reached 2% market penetration in 2009, after its 2007 introduction. As we know, that product is licensed from Covalon and I believe is substantially equivalent to the Silvercoat Foley catheter Covalon will be marketing. This white paper from Medline makes a pretty good case for it being better than the "competition": https://www.medline.com/irj/servlet/prt/portal/prtroot/pcd!3aportal_content!2fmedline!2fGlobal!2fPublicDocs/publicdocuments/Medline%20Documents/Marketing%20Materials/MarketingDocuments_N-Z/SIlvertouch%20Brochure%20MKT210104%20LIT498.pdf
I am quite optimistic about the possibilities this opens up for Covalon.
"Our houses are such unwieldy property that we are often imprisoned rather than housed in them." - Henry David Thoreau, Walden: Economy, 1854
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM